isomethyleugenol has been researched along with Cerebral Gigantism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, Y; Qiao, Q; Reinberg, D; Wang, M; Xu, RM | 1 |
| Kamps, MP; Pasillas, MP; Shah, M | 1 |
2 other study(ies) available for isomethyleugenol and Cerebral Gigantism
| Article | Year |
|---|---|
The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
Topics: Computer Simulation; Crystallography, X-Ray; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Models, Molecular; Nuclear Proteins; Protein Structure, Secondary; Protein Structure, Tertiary; Sotos Syndrome; Structure-Activity Relationship | 2011 |
NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human sotos syndrome.
Topics: Haploinsufficiency; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Nuclear Proteins; Point Mutation; Protein Interaction Domains and Motifs; Recombinant Fusion Proteins; Sequence Alignment; Sequence Analysis, Protein; Sotos Syndrome; Transcription Factors; Ubiquitination | 2011 |